R Discovery

RDiscovery is a Japan-US cross-border venture capital firm that leverages its extensive global network to identify early-stage biotechnology discoveries. It turns early-stage innovations into transformational therapies. The product is for biotechnology innovators and companies seeking investment and development support, particularly those originating from leading Japanese academic institutions. RDiscovery invests in and develops technologies and companies that drive innovation in therapeutic development. It has launched the RDiscovery Fund, a new vehicle dedicated to fostering innovation originating in Japan. Through its in-house incubator, operated by its own team, the fund focuses on creating and scaling companies rooted in discoveries from Japanese academic institutions. The firm’s venture team provides financial, biotech, and translational expertise, and has been described by a funded company CEO as providing value-added money. Another funded company chairman noted that after closing an RDiscovery-led financing round, the team provided well-developed partnership opportunities with big pharma. A CSO from a funded company stated that the RDiscovery team keeps the company focused on value-accreting milestones, the right target indication, and the best service providers in the sector.